Why MannKind (MNKD) Could Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? MannKind (MNKD) , which belongs to the Zacks Medical - Biomedical and Genetics industry, could be a great candidate to consider.This biopharmaceutical company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 275%.For the last reported quarter, M ...